BMO Financial Group Completes Acquisition of General

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BMO Financial Group Completes Acquisition of General Electric Capital Corporation's Transportation Finance Business

CHICAGO, ILLINOIS and TORONTO, ONTARIO--(Marketwired - Dec. 1, 2015) -

Editors Note: There is a photo associated with this press release.

BMO Financial Group (TSX:BMO)(NYSE:BMO), and its wholly-owned Chicago-based subsidiary BMO Harris Bank N.A. (together, "BMO"), today announced the completion of the acquisition of General Electric Capital Corporation's Transportation Finance business. The acquisition enhances BMO's commercial banking franchise with the addition of North America's largest financier to the truck and trailer segment.

"We're welcoming the premier Transportation Finance business in the industry into BMO Financial Group," said David Casper, President and CEO, BMO Harris Bank. "The trucking industry is vital to the North American economy, and we intend to grow the business, building on the team's 40-year track record of providing industry expertise to its customers."

Based in Irving, TX, the newly named BMO Transportation Finance business services the entire supply chain, from industry-leading original equipment manufacturers and dealers to a diverse set of end-users. It operates out of 11 locations in the United States and four in Canada, with more than 600 employees. On closing, the business had net earning assets of approximately $11.9 billion (US$8.9 billion).

BMO Transportation Finance will continue to operate under the leadership of Dan Clark - who has been appointed Head, BMO Transportation Finance - and his management team.

"Customers have already told us that they are looking forward to having access to BMO's full array of commercial services," said Mr. Clark. "We look forward to continuing to provide them with the same level of exceptional customer service they have come to expect."

About BMO Financial Group

Established in 1817, BMO Financial Group is a highly diversified financial services provider based in North America. With total assets of approximately $642 billion as of October 31, 2015, and close to 47,000 employees, BMO provides a broad range of retail banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, Wealth Management and BMO Capital Markets.

Cautionary statement regarding forward-looking information

Certain statements in this press release are forward-looking statements under the United States Private Securities Litigation Reform Act of 1995 (and are made pursuant to the 'safe harbour' provisions of such Act) and applicable Canadian securities legislation. These forward-looking statements include, but are not limited to, statements with respect to plans for, and the expected financial impact of, the acquired transportation finance business and are typically identified by words such as "believe", "expect", "anticipate", "intend", "estimate", "plan", "will", "should", "may", "could" and other similar expressions.

By their nature, forward-looking statements are based on various assumptions and are subject to inherent risks and uncertainties. We caution readers of this press release not to place undue reliance on our forward-looking statements as the assumptions underlying such statements may not turn out to be correct and a number of factors could cause actual future results, conditions, actions or events to differ materially from the targets, expectations, estimates or intentions expressed in the forward-looking statements. Such factors include, but are not limited to: the anticipated benefits from the acquired transportation finance business, such as it being accretive to earnings and growing our commercial customer base, are not realized in the time frame anticipated or at all as a result of changes in general economic and market conditions, interest and exchange rates, monetary policy, laws and regulations (including changes to capital requirements) and their enforcement, and the degree of competition in the geographic and business areas in which the acquired transportation finance business currently operates; the ability to promptly and effectively integrate the acquired transportation finance business; and those other factors set out on page 30 of BMO's 2015 Management's Discussion and Analysis (MD&A). We caution that the foregoing list is not exhaustive of all possible factors. These factors should be considered in addition to other uncertainties and potential events, and the inherent uncertainty of forward-looking statements.

Assumptions about current and expected capital requirements, the acquired transportation finance business revenues and expenses, potential for earnings growth as well as costs associated with the transaction and expected synergies, were material factors we considered in our estimate of the acquired transportation finance business being accretive to BMO's earnings in 2016.

BMO does not undertake to update any forward-looking statement, whether written or oral, that may be made, from time to time, by the organization or on its behalf, except as required by law.

To view the photo associated with this press release, please visit the following link: www.marketwire.com/library/20151130-clarkcasper800.jpg .

Media Contacts: Patrick O'Herlihy, Chicago (312) 461-6970 patrick.o'herlihy@bmo.com Ralph Marranca, Toronto (416) 867-3996 ralph.marranca@bmo.com Investor Relations Contacts: Lisa Hofstatter, Toronto (416) 867-7019 lisa.hofstatter@bmo.com Christine Viau, Toronto (416) 867-6956 christine.viau@bmo.com www.bmo.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

TRIMEDX Earns Spot in 2024 Inspiring Workplaces Rankings

Updated Category News Views 62

TRIMEDX Recognized as One of the Top Inspiring Workplaces TRIMEDX, a leading name in clinical asset management, has proudly claimed the 30th spot on the 2024 Global Top 100 Inspiring Workplaces list. This esteemed recognition highlights organizations that prioritize people-first practices and create outstanding workplace environments. A Global Overview The Inspiring...

Continue Reading
Triumvirate Environmental Secures Major Investment Boost

Updated Category News Views 326

Triumvirate Environmental Announces $1.8 Billion Valuation Triumvirate Environmental, a prominent name in environmental services, has recently received a significant growth investment from Berkshire Partners, a well-respected private equity firm. This monumental partnership has led to Triumvirate being valued at $1.8 billion, a testament to its strong market position and...

Continue Reading
Investing in MSCI: A Journey Over 15 Years Explained

Updated Category News Views 198

The Growth of MSCI Over 15 Years MSCI (NYSE: MSCI) has demonstrated impressive performance over the past decade and a half, significantly outperforming the market. With an annualized return of 20.17%, MSCI has amassed a market capitalization of $43.82 billion. This remarkable performance speaks volumes about the company’s solid market positioning and timely strategic...

Continue Reading
Deckers Outdoor Surges in Premarket Trading After Strong Earnings Report

Updated Category News Views 243

Deckers Outdoor Impresses with Strong Financial Results Shares of Deckers Outdoor Corporation (NYSE: DECK) have recently experienced a notable increase in value. This uplift can be attributed to the company's impressive second-quarter earnings, which surpassed analysts' expectations. The casual footwear and apparel retailer reported revenue of $1.31 billion, significantly...

Continue Reading
Vitrolife Group Secures Major Financing Through Nordic Banks

Updated Category News Views 190

Vitrolife AB Strengthens Financial Backbone Vitrolife AB (publ) has taken a significant step towards enhancing its financial foundation by renewing and signing a loan agreement worth EUR 300 million. This strategic financial maneuver includes both a term loan and a revolving credit facility, aimed at refinancing existing debt while also providing resources for general...

Continue Reading